Interleukin-1 and neuronal injury (Q36202191)

12 August 2017

1 reference

title

Interleukin-1 and neuronal injury (English)

1 reference

12 August 2017

0 references

Pippa J Tyrrell

2

0 references

Stuart M. Allan

object named as

Stuart M Allan

series ordinal

1

0 references

Nancy Rothwell

series ordinal

3

object named as

Nancy J Rothwell

1 reference

PubMed ID

16034365

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Nature Reviews Immunology

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

629-640

1 reference

12 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nri1664

12 August 2017

0 references

cites work

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

1 reference

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes

21 January 2018

1 reference

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

A new nomenclature for IL-1-family genes

21 January 2018

1 reference

IL-1 and IL-18 receptors, and their extended family.

21 January 2018

1 reference

"Inflammatory" cytokines: neuromodulators in normal brain?

21 January 2018

1 reference

Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists

21 January 2018

1 reference

Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression

21 January 2018

1 reference

Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity

21 January 2018

1 reference

S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors

21 January 2018

1 reference

Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain

21 January 2018

1 reference

Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production

21 January 2018

1 reference

Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages

21 January 2018

1 reference

Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes

21 January 2018

1 reference

P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death

21 January 2018

1 reference

A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release

21 January 2018

1 reference

Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing

21 January 2018

1 reference

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

21 January 2018

1 reference

A neuromodulatory role of interleukin-1beta in the hippocampus

21 January 2018

1 reference

Cytokine-induced sickness behavior.

21 January 2018

1 reference

Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2

21 January 2018

1 reference

Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2)

21 January 2018

1 reference

IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells.

21 January 2018

1 reference

IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system

21 January 2018

1 reference

Endogenous interleukin-1 receptor antagonist is neuroprotective

21 January 2018

1 reference

Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat.

21 January 2018

1 reference

Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat.

21 January 2018

1 reference

Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

21 January 2018

1 reference

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential

21 January 2018

1 reference

Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice

21 January 2018

1 reference

Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor

21 January 2018

1 reference

Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

21 January 2018

1 reference

Interleukin-1beta exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic hippocampal slice cultures

21 January 2018

1 reference

Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury.

21 January 2018

1 reference

Fever in acute stroke worsens prognosis. A prospective study

21 January 2018

1 reference

Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome.

21 January 2018

1 reference

Cell type-specific interleukin-1beta signaling in the CNS.

21 January 2018

1 reference

Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury.

21 January 2018

1 reference

IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice

21 January 2018

1 reference

Cytokines and acute neurodegeneration

21 January 2018

1 reference

IL-1-regulated responses in astrocytes: relevance to injury and recovery

21 January 2018

1 reference

Interleukin-1: a master regulator of neuroinflammation

21 January 2018

1 reference

Immune function of microglia

21 January 2018

1 reference

Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells

21 January 2018

1 reference

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

21 January 2018

1 reference

Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli

21 January 2018

1 reference

Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation

21 January 2018

1 reference

CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown.

21 January 2018

1 reference

Different cytokine levels in thrombolysis patients as predictors for clinical outcome.

21 January 2018

1 reference

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.

21 January 2018

1 reference

Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.

21 January 2018

1 reference

Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study.

21 January 2018

1 reference

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

21 January 2018

1 reference

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

21 January 2018

1 reference

Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study

21 January 2018

1 reference

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

Recommendations for clinical trial evaluation of acute stroke therapies.

21 January 2018

1 reference

Trends in monitoring patients with aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity.

21 January 2018

1 reference

Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist

21 January 2018

1 reference

Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis

21 January 2018

1 reference

Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha.

21 January 2018

1 reference

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke

21 January 2018

1 reference

Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene.

21 January 2018

1 reference

Brain ischemia as a potential target of gene therapy

21 January 2018

1 reference

IL-10 reduces rat brain injury following focal stroke.

21 January 2018

1 reference

The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish

21 January 2018

1 reference

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

31 March 2020

1 reference

A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling

31 March 2020

1 reference

The interleukin 1 receptor family

31 March 2020

1 reference

Overview of interleukin-18: more than an interferon-gamma inducing factor.

31 March 2020

1 reference

Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration

31 March 2020

1 reference

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

31 March 2020

1 reference

The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

31 March 2020

1 reference

Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors

31 March 2020

1 reference

Cytokine-mediated neuronal apoptosis

31 March 2020

1 reference

Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha

31 March 2020

1 reference

Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats

31 March 2020

1 reference

Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats

31 March 2020

1 reference

Role of IL-1alpha and IL-1beta in ischemic brain damage.

31 March 2020

1 reference

Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor

31 March 2020

1 reference

Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases

31 March 2020

1 reference

Role of nitric oxide in the cerebrovascular and thermoregulatory response to interleukin-1 beta

31 March 2020

1 reference

Interleukin-1β and adverse effects on cerebral blood flow during long-term global hypoperfusion

31 March 2020

1 reference

Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

31 March 2020

1 reference

Interleukin-1beta promotes repair of the CNS.

31 March 2020

1 reference

Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins

31 March 2020

1 reference

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

31 March 2020

1 reference

Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.

31 March 2020

1 reference

The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

31 March 2020

1 reference

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

31 March 2020

1 reference

CINC‐1 is identified as an acute‐phase protein induced by focal brain injury causing leukocyte mobilization and liver injury

31 March 2020

1 reference

Fluorescent stilbene (BADS) binding proteins in anion-transporting epithelia

31 March 2020

1 reference

Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease

31 March 2020

1 reference

Association of interleukin-1 alpha gene polymorphism with cerebral infarction

31 March 2020

1 reference

Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro

31 March 2020

1 reference

Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals

31 March 2020

1 reference

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI1664

1 reference

PubMed ID

16034365

Dimensions Publication ID

12 August 2017

0 references

1 reference

PubMed ID

16034365